Adds details about targets
ZURICH, Oct 27 (Reuters) - Swiss drugmaker Novartis NOVN.Ssaid on Tuesday that third-quarter core net income was $3.47 billion, up from $3.21 billion a year ago.
Analysts polled by Refinitiv had, on average, forecast $3.2 billion.
For 2020, the Basel-based company broadened its core operating income growth forecast to low double-digit to mid-teen percentage rate growth, from a low double-digit range previously, while net sales are expected to grow in the mid-single-digit percentage range.
(Reporting by John Miller; editing by Brenna Hughes Neghaiwi)
((J.Miller@thomsonreuters.com; +41 58 306 7734; Reuters Messaging: email@example.com))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.